SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
OCATA THERAPEUTICS
An SI Board Since November 2010
Posts SubjectMarks Bans Symbol
134 5 0 OCAT
Emcee:  Savant Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
34ACT Announces Two New Appointments to Board of Directors Zohar Loshitzer, CEO Savant-12/6/2011
33Anyone else showing a Minus 256,603,448 shares?? lolSavant-11/7/2011
32Advanced Cell Technology to Host Conference Call on Wednesday, November 9th to Savant-11/7/2011
31Pfizer stem cell study highlights sea change for a controversial field OctoberSavant-10/10/2011
30ACT Receives Approval from Data and Safety Monitoring Board (DSMB) to Treat NextSavant-9/28/2011
29ACT Receives Approval for First Human Embryonic Stem Cell Trial in Europe MoorSavant-9/22/2011
28ACT Secures First Patent for Generating Hemangioblast Cells to Treat a Broad SpSavant-9/19/2011
27Advanced Cell Technology Announces 2011 Second Quarter Results Company Exits QSavant-8/8/2011
26Advanced Cell Technology to Host Conference Call to Discuss 2011 Second Quarter Savant-8/2/2011
25ACT Obtains Exclusive License for Hemangioblast Technology in North America JuSavant17/21/2011
24ACT Announces First Patients Undergo Embryonic Stem Cell Transplantation TreatmeSavant17/14/2011
23ACT Granted EU Orphan Medicinal Product Designation for hESC-Derived RPE Cells fSavant-6/27/2011
22ACT and Roslin Cells Announce Collaboration for Storage and Distribution of EmbrSavant-6/21/2011
21ACT Announces First Patients Enrolled in Two Clinical Trials Using Embryonic SteSavant-6/16/2011
20Advanced Cell Technology To Webcast 2011 Annual Stockholder's Meeting To be Savant-6/3/2011
19ACT Announces Oregon Health & Science University as Clinical Trial Site for Savant15/16/2011
18Advanced Cell Technology Announces 2011 First Quarter Results May 9, 2011 08:3Savant-5/9/2011
17MARLBOROUGH, Mass., May 5, 2011 /PRNewswire via COMTEX/ -- Advanced Cell TechnolSavant-5/5/2011
16Advanced Cell Technology Praises Federal Appeals Court Ruling Allowing for ContiSavant-5/2/2011
15ACT Announces UCLA Institutional Review Board (IRB) Approval of its Phase 1/2 ClSavant-4/28/2011
148:33AM Advanced Cell Tech. to be issued broad patent for human ES cell-derived RFJB-3/23/2011
13Advanced Cell Technology To Present at the 13th Annual BIO CEO & Investor CoSavant-2/11/2011
12Advanced Cell Technology Interim Chairman and CEO Gary Rabin to Present at OneMeSavant-1/12/2011
11Advanced Cell: Phase I/II Trial Will Be Prospective, Open-Label StudySavant-1/3/2011
10Advanced Cell Technology Secures $25 Million Funding Commitment Company Now VirSavant-12/31/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News